Cargando…
Structure–Activity Relationship Analysis of Rhosin, a RhoA GTPase Inhibitor, Reveals a New Class of Antiplatelet Agents
Current antiplatelet therapies have several clinical complications and are mostly irreversible in terms of suppressing platelet activity; hence, there is a need to develop improved therapeutic agents. Previous studies have implicated RhoA in platelet activation. Here, we further characterized the le...
Autores principales: | Dandamudi, Akhila, Seibel, William, Tourdot, Benjamin, Cancelas, Jose A., Akbar, Huzoor, Zheng, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961652/ https://www.ncbi.nlm.nih.gov/pubmed/36835579 http://dx.doi.org/10.3390/ijms24044167 |
Ejemplares similares
-
Rho GTPase Signaling in Platelet Regulation and Implication for Antiplatelet Therapies
por: Dandamudi, Akhila, et al.
Publicado: (2023) -
RhoA and Rac1 GTPases Differentially Regulate Agonist-Receptor Mediated Reactive Oxygen Species Generation in Platelets
por: Akbar, Huzoor, et al.
Publicado: (2016) -
RhoA GTPase controls cytokinesis and programmed necrosis of hematopoietic progenitors
por: Zhou, Xuan, et al.
Publicado: (2013) -
Protocol for structural and biochemical analyses of RhoA GTPase
por: Lin, Yuan, et al.
Publicado: (2021) -
RhoA of the Rho Family Small GTPases Is Essential for B Lymphocyte Development
por: Zhang, Shuangmin, et al.
Publicado: (2012)